Cargando…

Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection

BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bode, Lars, Bertrand, Kerri, Najera, Julia A., Furst, Annalee, Honerkamp-Smith, Gordon, Shandling, Adam D., Chambers, Christina D., Camerini, David, Campo, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702863/
https://www.ncbi.nlm.nih.gov/pubmed/36434204
http://dx.doi.org/10.1038/s41390-022-02360-w
_version_ 1784839741322035200
author Bode, Lars
Bertrand, Kerri
Najera, Julia A.
Furst, Annalee
Honerkamp-Smith, Gordon
Shandling, Adam D.
Chambers, Christina D.
Camerini, David
Campo, Joseph J.
author_facet Bode, Lars
Bertrand, Kerri
Najera, Julia A.
Furst, Annalee
Honerkamp-Smith, Gordon
Shandling, Adam D.
Chambers, Christina D.
Camerini, David
Campo, Joseph J.
author_sort Bode, Lars
collection PubMed
description BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the antigenic regions of SARS-CoV-2 proteins that were reactive with antibodies in breast milk. METHODS: Between March 2020 and September 2020, 21 women with confirmed SARS-CoV-2 infection were enrolled in Mommy’s Milk. Participants donated serial breast milk samples around their time of illness. Breast milk samples were used to probe a multi-coronavirus protein microarray containing full-length and variable-length overlapping fragments of SARS-CoV-2 proteins. Samples were also tested against S and N proteins by electrochemiluminescence assay. RESULTS: The breast milk samples contained IgA reactive with a variety of SARS-CoV-2 antigens. The most IgA-reactive SARS-CoV-2 proteins were N (42.9% of women responded to ≥1 N fragment) and S proteins (23.9% responded to ≥1 fragment of S1 or S2). IgG responses were similar. A striking observation was the dissimilarity between mothers in antibody recognition, giving distinct antibody reactivity and kinetic profiles. CONCLUSIONS: Individual COVID-19 cases had diverse and unique milk IgA profiles following the onset of symptoms. IMPACT: In this observational longitudinal case series of 21 women with confirmed SARS-CoV-2 infection, IgA binding to SARS-CoV-2 proteins detected by orthologous proteome microarray and electrochemiluminescence assays was observed in >75% of women, but there was heterogeneity in which antigens and how many were reactive between women. Immunological profiles of protein regions recognized by each woman were distinct. Diverse repertoires of mucosal breast milk antibody to SARS-CoV-2 reflect heterogeneous passive transfer of maternal antibody to exposed breastfeeding infants.
format Online
Article
Text
id pubmed-9702863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-97028632022-11-28 Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection Bode, Lars Bertrand, Kerri Najera, Julia A. Furst, Annalee Honerkamp-Smith, Gordon Shandling, Adam D. Chambers, Christina D. Camerini, David Campo, Joseph J. Pediatr Res Clinical Research Article BACKGROUND: One potential mechanism for protection from SARS-CoV-2 in children is through passive immunity via breast milk from a mother infected with the novel coronavirus. The primary objectives of this study were to establish the presence of SARS-CoV-2-specific IgA and IgG and to characterize the antigenic regions of SARS-CoV-2 proteins that were reactive with antibodies in breast milk. METHODS: Between March 2020 and September 2020, 21 women with confirmed SARS-CoV-2 infection were enrolled in Mommy’s Milk. Participants donated serial breast milk samples around their time of illness. Breast milk samples were used to probe a multi-coronavirus protein microarray containing full-length and variable-length overlapping fragments of SARS-CoV-2 proteins. Samples were also tested against S and N proteins by electrochemiluminescence assay. RESULTS: The breast milk samples contained IgA reactive with a variety of SARS-CoV-2 antigens. The most IgA-reactive SARS-CoV-2 proteins were N (42.9% of women responded to ≥1 N fragment) and S proteins (23.9% responded to ≥1 fragment of S1 or S2). IgG responses were similar. A striking observation was the dissimilarity between mothers in antibody recognition, giving distinct antibody reactivity and kinetic profiles. CONCLUSIONS: Individual COVID-19 cases had diverse and unique milk IgA profiles following the onset of symptoms. IMPACT: In this observational longitudinal case series of 21 women with confirmed SARS-CoV-2 infection, IgA binding to SARS-CoV-2 proteins detected by orthologous proteome microarray and electrochemiluminescence assays was observed in >75% of women, but there was heterogeneity in which antigens and how many were reactive between women. Immunological profiles of protein regions recognized by each woman were distinct. Diverse repertoires of mucosal breast milk antibody to SARS-CoV-2 reflect heterogeneous passive transfer of maternal antibody to exposed breastfeeding infants. Nature Publishing Group US 2022-11-25 2023 /pmc/articles/PMC9702863/ /pubmed/36434204 http://dx.doi.org/10.1038/s41390-022-02360-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Research Article
Bode, Lars
Bertrand, Kerri
Najera, Julia A.
Furst, Annalee
Honerkamp-Smith, Gordon
Shandling, Adam D.
Chambers, Christina D.
Camerini, David
Campo, Joseph J.
Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title_full Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title_fullStr Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title_full_unstemmed Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title_short Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection
title_sort characterization of sars-cov-2 antibodies in human milk from 21 women with confirmed covid-19 infection
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702863/
https://www.ncbi.nlm.nih.gov/pubmed/36434204
http://dx.doi.org/10.1038/s41390-022-02360-w
work_keys_str_mv AT bodelars characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT bertrandkerri characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT najerajuliaa characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT furstannalee characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT honerkampsmithgordon characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT shandlingadamd characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT chamberschristinad characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT camerinidavid characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection
AT campojosephj characterizationofsarscov2antibodiesinhumanmilkfrom21womenwithconfirmedcovid19infection